Top Markets
#1 Tornado Cash Tornado Cash +5.42%
#2 Story Story +4.55%
#3 MVL MVL +3.98%
#4 Dual Dual +2.86%
#5 TENDIES TENDIES +2.76%
#6 UnifAI Network UnifAI Network +2.62%
#7 Figure Heloc Figure Heloc +2.55%
#8 WAX WAX +2.47%
#9 Orochi Network Orochi Network +2.35%
#10 KOTAI KOTAI +2.19%
Coin of the day
Tornado Cash Tornado Cash
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
AP Biosciences Inc AP Biosciences Inc

AP Biosciences Inc

6945
Classement en actions #16392
AP Biosciences Inc. is a pioneering clinical-stage biopharmaceutical company... AP Biosciences Inc. is a pioneering clinical-stage biopharmaceutical company dedicated to the research and development of bispecific antibody drugs, aiming to fulfill critical unmet medical needs. Its robust pipeline features several promising candidates: Leading the pack, IBI302 is in Phase III clinical trials for the treatment of neovascular age-related macular degeneration (nAMD). Further along, AP505 is undergoing Phase I clinical trials for various solid tumors. AP203, also in Phase I, is being investigated for non-small cell lung cancer, head and neck squamous cell carcinoma, and esophageal squamous cell carcinomas. In earlier development, AP402 is currently in the pre-clinical research phase, focusing on breast cancer patients. Additionally, AP601 is also in pre-clinical research, targeting a broader spectrum of malignancies including lung cancer, pancreatic cancer, bladder cancer, ovarian cancer, and other solid tumors. Founded in 2013, the company maintains its headquarters in Taipei City, Taiwan.
Prix de l'action
$3.06
Capitalisation boursière
$296.40M
Changement (1 jour)
-2.24%
Changement (1 an)
-22.64%
Pays
TW
Échange AP Biosciences Inc (6945)

Catégorie

Healthcare
Historique du prix de l'action pour AP Biosciences Inc (6945)
Prix de clôture le plus élevé : $3.06 le 2026-09-01

Prix de clôture le plus bas : $2.10 le 2023-07-01
Historique du prix de l'action de AP Biosciences Inc de 2023 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -13.12%
2025 237.19%
2024 4.26%
2023 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 36.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.33%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 536.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -10.53%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $748.60 6.90%
CH